← Back to Clinical Trials
Recruiting NCT05922462

NCT05922462 Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05922462
Status Recruiting
Phase
Sponsor Brock University
Condition Bone Growth Abnormal
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2023-09-01
Primary Completion 2025-08-30

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 22 Years
Study Type INTERVENTIONAL
Interventions
Greek yogurtWhey protein

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2023-09-01 with a primary completion date of 2025-08-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Physical activity and dairy consumption during growth and development are each known to improve peak bone mass in young adults. Peak bone mass, the maximum amount of bone a person will have in their lifetime, is typically reached in the early 20's in females and late 20's in males. However, evidence suggests that young people do not consume enough dairy to maximize their bone mass. The resulting effect in peak bone mass can be troublesome, particularly for athletes, such as volleyball players. This study aims to determine whether increased dairy consumption combined with training can have an additive effect on the physiology of young competitive athletes. Specifically, we will examine whether Greek yogurt consumption will lead to beneficial changes in bone metabolism and inflammation, in adolescent and young adult, male and female athletes, similar to those observed with whey protein supplementation. Many athletes choose exclusively protein supplementation and miss out on other nutrients vital for healthy growth and development. By examining the benefits of Greek yogurt across different athlete age groups and sexes, this work will help reshape the attitudes, beliefs, and behaviours surrounding diet of young athletes.

Eligibility Criteria

Inclusion Criteria: * Competitive youth or varsity athletes Exclusion Criteria: * Presence of injury * Inability to participate in practices * Allergy to dairy foods/dairy protein or * Diagnosis with lactose intolerance

Contact & Investigator

Central Contact

Panagiota Klentrou, PhD

✉ nklentrou@brocku.ca

📞 9056885550

Principal Investigator

Panagiota Klentrou, PhD

PRINCIPAL INVESTIGATOR

Brock University

Frequently Asked Questions

Who can join the NCT05922462 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 22 Years, studying Bone Growth Abnormal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05922462 currently recruiting?

Yes, NCT05922462 is actively recruiting participants. Contact the research team at nklentrou@brocku.ca for enrollment information.

Where is the NCT05922462 trial being conducted?

This trial is being conducted at St. Catharines, Canada.

Who is sponsoring the NCT05922462 clinical trial?

NCT05922462 is sponsored by Brock University. The principal investigator is Panagiota Klentrou, PhD at Brock University. The trial plans to enroll 40 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology